Meta ‐analysis of laparoscopic versus open liver resection for hepatocellular carcinoma
Hepatology Research, EarlyView. (Source: Hepatology Research)
Source: Hepatology Research - April 1, 2018 Category: Internal Medicine Source Type: research

Compartment model analysis of intravenous contrast ‐enhanced dynamic computed tomography in hepatic hemodynamics: A validation study using intra‐arterial contrast‐enhanced computed tomography
Hepatology Research, EarlyView. (Source: Hepatology Research)
Source: Hepatology Research - March 30, 2018 Category: Internal Medicine Authors: DaisukeKomatsu , AkiraYamada , TakeshiSuzuki , MasahiroKurozumi , YasunariFujinaga , KazuhikoUeda , MasumiKadoya Source Type: research

Long ‐term outcome of stereotactic body radiotherapy for patients with small hepatocellular carcinoma
Hepatology Research,Volume 48, Issue 9, Page 701-707, August 2018. (Source: Hepatology Research)
Source: Hepatology Research - March 23, 2018 Category: Internal Medicine Authors: KatsumaroKubo , TomokiKimura , HiroshiAikata , ShigeoTakahashi , YukiTakeuchi , IppeiTakahashi , IkunoNishibuchi , YujiMurakami , KazuakiChayama , YasushiNagata Source Type: research

Long ‐term outcome of stereotactic body radiotherapy for patients with small hepatocellular carcinoma
Hepatology Research, EarlyView. (Source: Hepatology Research)
Source: Hepatology Research - March 23, 2018 Category: Internal Medicine Source Type: research

---
Hepatology Research, Ahead of Print. (Source: Hepatology Research)
Source: Hepatology Research - March 23, 2018 Category: Internal Medicine Source Type: research

Multicenter, randomized, controlled trial of S ‐1 monotherapy versus S‐1 and interferon‐α combination therapy for hepatocellular carcinoma with extrahepatic metastases
Hepatology Research,Volume 48, Issue 9, Page 717-726, August 2018. (Source: Hepatology Research)
Source: Hepatology Research - March 12, 2018 Category: Internal Medicine Authors: HiroakiNagano , ShuntaroObi , EtsuroHatano , ShuichiKaneko , FumihikoKanai , MasaoOmata , AkihitoTsuji , ToshiyukiItamoto , KazuhideYamamoto , MasatoshiTanaka , ShojiKubo , KoichiHirata , HidejiNakamura , YoshitoTomimaru , Tak Source Type: research

Fatty liver index predicts incident diabetes in a Japanese general population with and without impaired fasting glucose
Hepatology Research,Volume 48, Issue 9, Page 708-716, August 2018. (Source: Hepatology Research)
Source: Hepatology Research - March 12, 2018 Category: Internal Medicine Authors: AyaHirata , DaisukeSugiyama , KazuyoKuwabara , TakumiHirata , HiromiTsutatani , MikaFunamoto , KouitiWatanabe , NaomiMiyamatsu , TomonoriOkamura Source Type: research

Multicenter, randomized, controlled trial of S ‐1 monotherapy versus S‐1 and interferon‐α combination therapy for hepatocellular carcinoma with extrahepatic metastases
Hepatology Research, EarlyView. (Source: Hepatology Research)
Source: Hepatology Research - March 12, 2018 Category: Internal Medicine Source Type: research

Fatty liver index predicts incident diabetes in a Japanese general population with and without impaired fasting glucose
Hepatology Research, EarlyView. (Source: Hepatology Research)
Source: Hepatology Research - March 12, 2018 Category: Internal Medicine Source Type: research

Higher efficacy of pegylated interferon ‐α2b add‐on therapy in hepatitis B envelope antigen‐positive chronic hepatitis B patients on tenofovir monotherapy
Hepatology Research, EarlyView. (Source: Hepatology Research)
Source: Hepatology Research - March 12, 2018 Category: Internal Medicine Source Type: research

---
Hepatology Research, Ahead of Print. (Source: Hepatology Research)
Source: Hepatology Research - March 12, 2018 Category: Internal Medicine Source Type: research

Multicenter, randomized, controlled trial of S ‐1 monotherapy versus S‐1 and interferon‐α combination therapy for hepatocellular carcinoma with extrahepatic metastases
ConclusionsOncological outcomes in both treatment groups were favorable compared with previous reports, though there was no significant beneficial effect of adding IFN‐α to S‐1 for the treatment of HCC patients with extrahepatic metastases. (Source: Hepatology Research)
Source: Hepatology Research - March 12, 2018 Category: Internal Medicine Authors: Hiroaki Nagano, Shuntaro Obi, Etsuro Hatano, Shuichi Kaneko, Fumihiko Kanai, Masao Omata, Akihito Tsuji, Toshiyuki Itamoto, Kazuhide Yamamoto, Masatoshi Tanaka, Shoji Kubo, Koichi Hirata, Hideji Nakamura, Yoshito Tomimaru, Takeharu Yamanaka, Shinsuke Koji Tags: Original Article Source Type: research